<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Ratze MAK</submitter><funding>National Centre for the Replacement, Refinement and Reduction of Animals in Research</funding><funding>Medical Research Council</funding><funding>Dutch Research Council (NWO)</funding><pagination>2932-2944</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9122823</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>41(21)</volume><pubmed_abstract>Invasive lobular breast carcinoma (ILC) is characterized by proliferative indolence and long-term latency relapses. This study aimed to identify how disseminating ILC cells control the balance between quiescence and cell cycle re-entry. In the absence of anchorage, ILC cells undergo a sustained cell cycle arrest in G0/G1 while maintaining viability. From the genes that are upregulated in anchorage independent ILC cells, we selected Inhibitor of DNA binding 2 (Id2), a mediator of cell cycle progression. Using loss-of-function experiments, we demonstrate that Id2 is essential for anchorage independent survival (anoikis resistance) in vitro and lung colonization in mice. Importantly, we find that under anchorage independent conditions, E-cadherin loss promotes expression of Id2 in multiple mo</pubmed_abstract><journal>Oncogene</journal><pubmed_title>Loss of E-cadherin leads to Id2-dependent inhibition of cell cycle progression in metastatic lobular breast cancer.</pubmed_title><pmcid>PMC9122823</pmcid><funding_grant_id>NC/P001262/1</funding_grant_id><funding_grant_id>016.096.318</funding_grant_id><pubmed_authors>Sijnesael T</pubmed_authors><pubmed_authors>Bassey-Archibong B</pubmed_authors><pubmed_authors>Enserink L</pubmed_authors><pubmed_authors>O'Leary L</pubmed_authors><pubmed_authors>Bakker ERM</pubmed_authors><pubmed_authors>Richard F</pubmed_authors><pubmed_authors>Derksen PWB</pubmed_authors><pubmed_authors>Viciano I</pubmed_authors><pubmed_authors>Roca-Cusachs P</pubmed_authors><pubmed_authors>Jaksani S</pubmed_authors><pubmed_authors>Isacke CM</pubmed_authors><pubmed_authors>Visser D</pubmed_authors><pubmed_authors>van Diest PJ</pubmed_authors><pubmed_authors>Desmedt C</pubmed_authors><pubmed_authors>van de Ven R</pubmed_authors><pubmed_authors>Ratze MAK</pubmed_authors><pubmed_authors>Tutt A</pubmed_authors><pubmed_authors>Daniel JM</pubmed_authors><pubmed_authors>Koorman T</pubmed_authors><pubmed_authors>Fitzpatrick A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Loss of E-cadherin leads to Id2-dependent inhibition of cell cycle progression in metastatic lobular breast cancer.</name><description>Invasive lobular breast carcinoma (ILC) is characterized by proliferative indolence and long-term latency relapses. This study aimed to identify how disseminating ILC cells control the balance between quiescence and cell cycle re-entry. In the absence of anchorage, ILC cells undergo a sustained cell cycle arrest in G0/G1 while maintaining viability. From the genes that are upregulated in anchorage independent ILC cells, we selected Inhibitor of DNA binding 2 (Id2), a mediator of cell cycle progression. Using loss-of-function experiments, we demonstrate that Id2 is essential for anchorage independent survival (anoikis resistance) in vitro and lung colonization in mice. Importantly, we find that under anchorage independent conditions, E-cadherin loss promotes expression of Id2 in multiple mo</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 May</publication><modification>2025-04-04T07:34:19.781Z</modification><creation>2025-02-19T01:24:00.292Z</creation></dates><accession>S-EPMC9122823</accession><cross_references><pubmed>35437308</pubmed><doi>10.1038/s41388-022-02314-w</doi></cross_references></HashMap>